Acoramidis’s hazard ratio of .41 for time to ACM or first CVH versus placebo in the ATTRibute-CM study subgroup of ATTRv-CM ...

BridgeBio Pharma’s Beyonttra to treat transthyretin-mediated amyloid cardiomyopathy receives Japanese approval: Palo Alto, California Monday, March 31, 2025, 17:00 Hrs [IST] Bri ...

Studies on NTLA's gene-edited therapy, nex-z, are progressing well while other pipelines are picking up pace. Stiff competition in the target market is a woe.

Pharmaceuticals announced moderated poster presentations of new data from the HELIOS-B Phase 3 clinical trial, which evaluated ...

Researchers at ACC suggested stratifying by age and TTR variant, plus cascade testing, could help identify those likely to ...

Chanel Tapper, a California resident, holds the Guinness World Record for the longest female tongue, measuring 9.75 cm (3.8 inches) from tip to top lip.

An electric eraser could also be a timesaver. In the days before computer-aided drawing and the ease of the delete and undo ...

Redburn Atlantic initiated coverage of BridgeBio with a Buy rating and $50 price target Therapeutic options for patients with transthyretin ...

Results from an accuracy benchmark over the CommonVoice5.1 dataset show the Salad Transcription API achieved the highest Word ...

If your home has some hard-to-reach areas that require manual cleaning or that get missed entirely, the Roborock F25 Ace ...

Patients with narrowing of at least 50% in three major coronary arteries did equally well when treated with a minimally invasive stent placement guided either by ultrasound-based imaging or by a novel ...

Clinical researcher Nadine Spring discusses the long-standing lack of diversity in clinical trials and why she's fighting for ...